William Blair Has Pessimistic Outlook of AXSM Q1 Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Stock analysts at William Blair reduced their Q1 2025 earnings per share (EPS) estimates for Axsome Therapeutics in a report issued on Tuesday, April 1st. William Blair analyst M. Minter now anticipates that the company will post earnings of ($1.49) per share for the quarter, down from […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Stock analysts at William Blair reduced their Q1 2025 earnings per share (EPS) estimates for Axsome Therapeutics in a report issued on Tuesday, April 1st. William Blair analyst M. Minter now anticipates that the company will post earnings of ($1.49) per share for the quarter, down from […]
